Could a simple block test detect 'Silent' brain fog in liver disease?
NCT ID NCT06619106
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a new cognitive test using building blocks to quickly screen for minimal hepatic encephalopathy (MHE), a subtle brain complication in people with liver disease. Researchers will compare the test's accuracy against standard methods in 100 adults with liver fibrosis, cirrhosis, or porto-systemic shunts. If proven reliable, it could offer a faster, simpler way to diagnose MHE.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cognitive test using building blocks
- What this could lead to
- If successful, this could provide a quick, reliable screening tool for minimal hepatic encephalopathy, helping doctors diagnose it earlier and more accurately.
- What could go wrong
- This is a small pilot study (100 participants) testing a new tool against existing tests. It may not prove accurate enough or may not work in broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC PATHOLOGY (FIBROSIS, CIRRHOSIS, PORTO SYSTEMIC SHUNTS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hepato-gastro-enterology department, Pitié Salpêtrière hospital
RECRUITINGParis, 75013, France